|
About Us > PipelinePipelineDynavax is developing a diversified pipeline of novel Toll-like Receptor (TLR) based product candidates for infectious, respiratory, autoimmune, and inflammatory diseases.
|
|
Copyright © 2000–2009 Dynavax Technologies Corporation. All rights reserved. |
